Title: Interventional Oncology Devices Market
1Interventional Oncology Devices Market Size Worth
USD 3.11 Billion by 2027
www.emergenresearch.com
The rising government initiatives and the
increasing preference for minimally invasive
procedures are driving the demand for the market.
2Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4Industries We Cater to
www.emergenresearch.com
5
5Market Summary
The global Interventional Oncology Devices
Market is forecasted to be worth USD 3.11 Billion
by 2027, according to a current analysis by
Emergen Research. Due to the increasing
preference for minimally invasive treatments, the
global Interventional Oncology Devices market is
expected to proliferate. It is anticipated that
increasing government initiatives to encourage
Interventional Oncology will further boost the
market growth. Besides, the rising technological
advancements in the devices are also expected to
augment the market growth. The market growth in
the forecast timeline is expected to be impeded
by a lack of skilled oncologists and radiologists.
www.emergenresearch.com
6Market Summary
- Some Key Highlights from the Report
- In September 2020, The strategic investment in
Nanospectra Biosciences, Inc. was announced by
Sirtex Medical Limited. The investment will offer
funding to improve further Nanospectra 's leading
prostate cancer tissue ablation device AuroLase,
the first and only ultra-focal ablation treatment
intended to enhance the efficiency of treatment,
reducing adverse effects related to anesthesia,
chemotherapy, and alternate focal therapies. In
order to destroy solid cancer tumors, this
treatment uses the company's patented AuroShells
nanoparticle technique to minimize the damage
of neighboring healthy tissue. - Over the forecasted timeline, the Embolization
segment accounted for the largest market with a
CAGR of 6.7, since it is a minimally invasive
therapy that offers advantages such as quick
recovery, can be practiced through local
anesthesia, and cost-effective. - It is anticipated that Bland Embolization or
Transcatheter Arterial Embolization will expand
significantly. This method is being used for the
treatment of liver tumors or for postsurgical
adjunctive treatment. - The segment of lung cancer will dominate the
market during the forecasted period since smoking
habits have increased the incidence of lung
cancer. - Due to the rising prevalence of cancer, easy
availability of interventional oncology, and the
fast adoption of technological advancement owing
to significant government spending on medical
treatment, the North American region is expected
to dominate the market. - Request Free Sample Copy_at_ https//www.emergenresea
rch.com/request-sample/387
www.emergenresearch.com
7Market Summary
Emergen Research has segmented the global
Interventional Oncology Devices Market on the
basis of product type, process, cancer type, and
region Product Type Outlook (Revenue, USD
Billion 2017-2027) Support Embolization Ablation
Process Outlook (Revenue, USD Billion
2017-2027) Non-Thermal Tumor Ablation Thermal
Tumor Ablation Transcatheter Arterial
Radioembolization Transcatheter Arterial
Chemoembolization Bland Embolization or
Transcatheter Arterial Embolization Read More_at_
https//www.emergenresearch.com/industry-report/in
terventional-oncology-devices-market
8Parameter Details
Market Size Estimation Period 2020-2027
Base Year Considered 2019
Historical Data 2016-2018
Forecast Period 2020-2027
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9Regional Share Dynamics
www.emergenresearch.com
10LATEST PUBLICATIONS
Latest published reports by Emergen Research
Point-Of-Sale Security Market https//www.emerge
nresearch.com/industry-report/point-of-sale-securi
ty-market Smart Insulin Delivery Patch
Market https//www.emergenresearch.com/industry-re
port/smart-insulin-delivery-patch-market Enterpr
ise Information Archiving Market https//www.emerg
enresearch.com/industry-report/enterprise-informat
ion-archiving-market Public Safety and Security
Market https//www.emergenresearch.com/industry-re
port/public-safety-and-security-market Patient
Blood Management Market https//www.emergenresearc
h.com/industry-report/patient-blood-management-mar
ket
www.emergenresearch.com
11About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
www.emergenresearch.com
12Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 (604) 757-9756